Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jan 29, 2025

SELL
$47.98 - $54.4 $27,060 - $30,681
-564 Reduced 51.6%
529 $28.7 Million
Q4 2023

Jan 29, 2025

BUY
$48.48 - $57.85 $52,988 - $63,230
1,093 New
1,093 $56.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Louisbourg Investments Inc. Portfolio

Follow Louisbourg Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisbourg Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Louisbourg Investments Inc. with notifications on news.